Navigation Links
Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase
Date:10/12/2007

NEW YORK, Oct. 12 /PRNewswire/ -- New products, a growing world population expected to reach 6.8 billion in three years, as well as the aging of that population, will push anesthesia drug sales 1.9% to nearly $4.3 billion by 2011, according to Anesthesia Drugs: Worldwide Markets, a new report by Kalorama Information.

More than 300 million surgical procedures required anesthetic administration worldwide in 2006, and Kalorama Information expects that number will rise accordingly as the incidence and prevalence of disease grows with the world population.

Adjunctive therapies, drugs given in the perioperative period to facilitate and/or augment the anesthetic process, will likely represent the largest percentage of growth during the forecast period primarily due to new developments in the anesthesia reversal market. The adjunctive therapies market grew from $793.3 million in 2004 to $825.5 million in 2006 and is expected to reach $1.2 billion by 2011, an increase of 8.2%.

Trends affecting future growth of anesthesia drugs include research and development in several promising areas, including the treatment of depression and sleep disorders and the growing use of conscious sedation, a procedure that involves sedative drugs that lower the level of consciousness but doesn't put a patient completely under.

"The availability of sedating drugs, such as fentanyl and Versed, has been a real boon to the industry," said Melissa Elder, author of Anesthesia Drugs. "Advancements in the area of conscious sedation have resulted in nearly 70% of surgical procedures being performed in hospital outpatient departments, surgical centers, and doctor's offices, which allow doctors to perform operations ranging from tummy tucks to cardiac catheterizations without the need for general anesthesia or an overnight hospital stay."

Anesthesia Drugs covers both currently marketed and late stage development anesthesia drugs worldwide with special emphasis on general, local, and adjunctive therapies in anesthesia in the U.S. The report analyzes products in development and on the market, leading competitors, and current issues and trends affecting the industry. This report can be purchased directly from Kalorama Information by visiting https://www.kaloramainformation.com/Anesthesia-Drugs-Worldwide-1399472/. It is also available at MarketResearch.com.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research on medical markets. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.


'/>"/>
SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
3. General Anesthesia For Heroin Detoxification Is No Good
4. Anesthesia Drug To Bring Solace To The Depressed
5. Choice of Anesthesia in C-section
6. Dental Researchers Test No-Needle Anesthesia, No-Drilling Cavity Care
7. Targeted Anesthesia Can Minimize Pain During Prostate Biopsy
8. Obstetrical Anesthesia Equally Safe When Provided by CRNAs or Anesthesiologists
9. Two New Anesthesia Positions Promise to Ease Surgery Queue
10. Lean Protein Could Be Key to Obesity Drugs
11. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in ... to a study appearing online in the journal Radiology. , Heart disease and brain ... significantly due to the rapidly aging population. Damage to both organs often occurs at ...
(Date:12/7/2016)... Arbor, MI (PRWEB) , ... December 07, 2016 ... ... insurance and financial consultation services from offices located in South Lyon, Dewitt, Williamston, ... to benefit a basketball coach who needs treatment for a brain tumor. , ...
(Date:12/7/2016)... ... 07, 2016 , ... AlignLife clinics nationwide are giving back to their communities ... to receive bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to ... the world. , In exchange for generous donations, customers will receive a gift in ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... proud to announce that its fully redesigned website, which launched October 17, 2016, ... a sleek responsive design and easy-to-navigate layout. Visitors and patients can discover the ...
(Date:12/7/2016)... ... December 07, 2016 , ... 1105 Media’s Live From ... Folio: Marketing Awards competition. Live From won in the Use of Social Media ... ultimately successful projects undertaken by the media industry’s most innovative marketing professionals. ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)...   Arena Pharmaceuticals, Inc. (NASDAQ: ... in the ralinepag phase 2 trial.  Ralinepag is an ... for the treatment of pulmonary arterial hypertension (PAH). The ... "This marks an important step in the development ... on our pipeline," said Amit Munshi , Arena,s ...
(Date:12/7/2016)... Pharmacy, Inc. (NYSE: DPLO) has launched Diplomat Specialty Infusion Group, a ... BioRx, MedPro Rx, and XAS Infusion Suites. To learn ... ... Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ... continue to build on the work we have done, we are ...
(Date:12/7/2016)... PARK, Kan. , Dec. 7, 2016   Rx ... of West Virginia and its Public Employees Insurance ... plan members access to their innovative healthcare software, ultimately saving ... partner with PEIA and provide its members with access to ... changes or a more effective, affordable therapy can be found," ...
Breaking Medicine Technology: